Gene sequence sequencing and analysis is the process of determining the precise order of nucleotides within a DNA or RNA molecule and interpreting that information through validated bioinformatics pipelines. From Sanger sequencing to next-generation sequencing (NGS) and long-read platforms, this technology underpins clinical diagnostics, microbial identification, agricultural genomics, and biopharmaceutical quality control. This guide explains the sequencing workflow, sample requirements, testing items, analytical methods, and quality standards used by accredited third-party laboratories.
Technical Overview
Gene sequencing analysis refers to the laboratory and computational process of reading the nucleotide sequence of DNA or RNA molecules and deriving biologically meaningful conclusions from the resulting data. The technology has evolved through three principal generations: first-generation Sanger sequencing based on chain-termination chemistry and capillary electrophoresis; second-generation massively parallel sequencing (commonly known as next-generation sequencing, or NGS), which generates millions of short reads simultaneously; and third-generation single-molecule long-read platforms that produce reads tens of kilobases in length and can resolve complex structural regions.
A complete sequencing project integrates several stages: nucleic acid extraction, sample quality control, library preparation, platform sequencing, basecalling, bioinformatics analysis, and result interpretation. Depending on the application, the analytical scope may range from a single PCR amplicon of a few hundred base pairs to an entire human genome of approximately three billion base pairs. Sequencing services are typically performed in laboratories operating under ISO/IEC 17025 general requirements for the competence of testing laboratories, while clinical sequencing laboratories commonly comply with ISO 15189 medical laboratory requirements. Quantitative molecular methods supporting sequencing workflows may follow ISO 20395 performance criteria for nucleic acid amplification assays.
Testing Samples
Human and Animal Clinical Samples
Accepted clinical specimens include peripheral blood collected in EDTA anticoagulant tubes, buccal swabs, fresh-frozen tissue, formalin-fixed paraffin-embedded (FFPE) tissue sections, bone marrow aspirates, and cell pellets. FFPE samples require specialized extraction protocols because formalin cross-linking fragments nucleic acids, and results must be interpreted with awareness of degraded template quality.
Microbial Samples
Bacterial and fungal pure cultures grown on appropriate solid or liquid media are the most common substrates for species identification and whole-genome sequencing. Colony material should be freshly harvested, and cultures must be pure, as mixed populations compromise assembly quality and species-level calls.
Plant and Agricultural Samples
Fresh leaves, seeds, roots, and processed plant material are suitable for DNA barcoding, transgenic event verification, and varietal identification. Young leaf tissue is preferred because it contains high-molecular-weight DNA with minimal secondary metabolite interference.
Purified Nucleic Acid Material
Laboratories also accept previously extracted genomic DNA, total RNA, plasmid DNA, PCR amplicons, and cDNA. For direct submission, typical acceptance criteria include:
- Concentration measured by fluorometric methods, with most applications requiring at least 20 ng to 1 µg of input DNA depending on the assay scope
- Purity ratios of A260/280 between 1.8 and 2.0 and A260/230 above 1.8, indicating minimal protein and organic contamination
- Integrity verified by gel electrophoresis or automated electrophoretic systems, with intact genomic DNA showing minimal smearing
- RNA samples assessed with an integrity number (RIN) typically above 7 for transcriptome applications
Environmental and Food Matrix Samples
Soil, water, swabs from processing environments, and food matrices can be submitted for metagenomic or amplicon-based microbiome analysis. These complex matrices require bead-beating extraction and inhibitor removal steps before library construction.
Testing Items
Sequencing service portfolios generally cover the following categories of testing, each matched to a specific analytical objective:
- Sanger sequencing of individual PCR products and plasmids for construct verification, clone confirmation, and CRISPR edit validation
- Whole genome sequencing (WGS) for de novo assembly or reference-based mapping of bacterial, fungal, plant, animal, and human genomes
- Whole exome sequencing (WES) targeting the protein-coding regions of the human genome for inherited disease investigation
- Targeted gene panel sequencing covering curated sets of disease-associated, pharmacogenomic, or trait-linked loci
- 16S rRNA and ITS amplicon sequencing for bacterial and fungal community profiling and species identification
- Shotgun metagenomic sequencing for unbiased taxonomic profiling and functional gene prediction in complex samples
- Transcriptome sequencing (RNA-seq) for gene expression quantification, differential expression analysis, and fusion transcript detection
- Mitochondrial genome sequencing for maternal lineage, population genetics, and forensic applications
- DNA barcoding of standard loci such as COI, rbcL, matK, and ITS for species authentication of animals, plants, and fungi
- Variant analysis pipelines reporting single nucleotide variants (SNVs), insertions and deletions (indels), copy number variants (CNVs), and structural variants (SVs)
Each testing item carries defined deliverables, which may include raw sequencing data files, quality metrics, assembled contigs or mapped reads, annotated variant tables, phylogenetic trees, and an interpretive summary prepared by qualified analysts.
Testing Methods
A validated sequencing workflow follows a structured sequence of laboratory and computational steps, with quality control gates at every transition point.
Sample Receipt and Quality Control
Upon arrival, samples are accessioned with unique identifiers and inspected for condition and documentation completeness. Nucleic acid concentration is measured using fluorometric assays, purity is assessed by ultraviolet spectrophotometry, and integrity is evaluated by electrophoretic analysis. Samples failing predefined thresholds are flagged for re-extraction or communicated to the client with corrective recommendations.
Extraction and Library Preparation
DNA or RNA is extracted using silica-column, magnetic-bead, or organic solvent protocols appropriate to the matrix. For NGS platforms, extracted nucleic acids undergo fragmentation by enzymatic or mechanical means, end repair, adapter ligation, barcode indexing, and polymerase chain reaction (PCR) amplification. Targeted applications substitute these steps with multiplex PCR or hybrid-capture enrichment of regions of interest. Library size distribution and yield are confirmed before loading.
Sequencing Execution
Libraries are loaded onto the appropriate instrument. Sanger sequencing resolves single fragments through capillary electrophoresis and remains the reference method for confirming short, defined regions. Short-read NGS platforms perform sequencing-by-synthesis on massive parallel arrays, producing high-accuracy data suited to variant detection. Long-read single-molecule platforms generate extended reads valuable for resolving repetitive regions, phasing haplotypes, and completing microbial genome assemblies.
Bioinformatics Analysis
Raw signal data are converted into basecalled reads, which are then filtered for quality. The standard analytical pipeline includes:
- Quality trimming of adapters and low-confidence bases using established read-processing algorithms
- Alignment of reads to a reference genome or de novo assembly into contigs
- Variant calling, consensus sequence generation, or taxonomic classification depending on the assay design
- Functional annotation against curated databases for genes, resistance determinants, virulence factors, or clinical significance
- Statistical reporting of coverage depth, uniformity, base quality scores, and confidence metrics
Validation and Reporting
Findings undergo technical review, and clinically or regulatorily significant results are confirmed by an orthogonal method such as Sanger sequencing when required. Accredited third-party laboratories structure their reports in accordance with ISO/IEC 17025 requirements, documenting methods, equipment, quality metrics, limitations, and clear statements of result interpretation.
Applications
Gene sequencing analysis serves a broad spectrum of research, clinical, industrial, and regulatory purposes:
- Clinical genetics: diagnosis of inherited disorders, carrier screening, preimplantation and prenatal genetic testing, and molecular characterization of constitutional disease
- Oncology: tumor mutational profiling, companion diagnostic support, minimal residual disease monitoring, and circulating tumor DNA analysis through liquid biopsy
- Infectious disease: rapid pathogen identification, outbreak epidemiology and strain tracing, antimicrobial resistance gene detection, and genomic surveillance of evolving viruses
- Biopharmaceutical manufacturing: cell bank identity confirmation, plasmid sequence verification, adventitious agent testing support, and consistency evaluation of production strains
- Agriculture and breeding: marker-assisted selection, trait gene discovery, varietal purity assessment, and seed authenticity confirmation
- Food safety and authenticity: microbiome profiling of fermented products, spoilage organism identification, species authentication of meat and seafood, and detection of genetically modified events consistent with relevant ISO and national food standards
- Environmental monitoring: biodiversity assessment through environmental DNA, water quality evaluation, and microbial community tracking in soil and wastewater systems
- Forensic science: human identity testing, mitochondrial lineage analysis, and biological material attribution
FAQ
How long does a typical sequencing project take?
Sanger sequencing of purified PCR products or plasmids is usually completed within one to three working days. Small NGS projects such as microbial whole genome sequencing typically require one to two weeks, while large-scale projects such as whole exome sequencing or complex metagenomic analysis may require two to six weeks depending on sequencing depth, queue volume, and the extent of bioinformatics interpretation.
How do I choose between Sanger sequencing and NGS?
Sanger sequencing is the preferred method when the target region is short, previously defined, and requires high per-read accuracy, such as plasmid verification or confirmatory testing of a single variant. NGS is superior when many loci, many samples, unknown variants, or whole genomes must be interrogated simultaneously, offering far lower cost per base and scalable throughput.
Can degraded FFPE tissue samples be sequenced reliably?
Yes. Specialized short-amplicon library preparation and quality assessment protocols allow meaningful data recovery from FFPE material, although reduced coverage uniformity and artifactual variants must be controlled through validated pipelines. Long-read applications are generally not recommended for heavily degraded archival specimens.
What sample quantity and quality are required?
Requirements vary by application. Sanger sequencing needs nanogram quantities of purified PCR product, targeted panels may require 10 to 50 ng of DNA, and whole genome sequencing typically calls for at least 100 ng to 1 µg of high-integrity DNA. Laboratories provide submission guidelines specifying acceptable concentration, purity ratios, and shipping conditions, including cold-chain transport for RNA.
How is data quality assured and confidentiality protected?
Accredited laboratories apply documented quality management systems with instrument calibration, control materials at defined frequencies, sequencing depth thresholds, and software validation. Client data are handled under confidentiality agreements, with secure transfer of raw data files and controlled retention periods consistent with contractual and applicable regulatory requirements.
What accreditation should a sequencing service laboratory hold?
For research and industrial testing, ISO/IEC 17025 accreditation demonstrates general testing competence. For clinical diagnostic sequencing, ISO 15189 accreditation is the relevant medical laboratory standard. Additional method-specific conformance, such as ISO 20395 for quantitative molecular assays, provides further assurance of analytical validity for particular testing items.